Cetilistat - Investigational Drug for Obesity

Print

Figures from the American Heart Association suggest 20% to 25% of US adults have metabolic syndrome, for which obesity is a contributory factor.
 
«Back | Next»




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development